|
dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
AR2_0006 | ED149042 | General Research Use | No | Female | Black or African American | 62 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
AR2_0016 | ED149746 | General Research Use | No | Female | White | 64 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0104 | ED149157 | General Research Use | No | Female | White | 80 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0135 | ED148553 | General Research Use | No | Female | White | 68 | 6 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
AR2_0171 | ED148568 | General Research Use | No | Female | White | 74 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0360 | ED149667 | General Research Use | No | Female | White | 82 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0395 | ED148706 | General Research Use | No | Female | White | 70 | 6 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
AR2_0519 | ED149482 | General Research Use | No | Female | White | 73 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0562 | ED148400 | General Research Use | No | Female | White | 61 | 6 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0563 | ED149060 | General Research Use | No | Male | White | 76 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
AR2_0690 | ED148855 | Eye Disease Only | No | Female | White | 67 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0730 | ED149828 | General Research Use | No | Female | White | 71 | 6 - AREDS AMD Severity Scale Step 5 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_0742 | ED149449 | General Research Use | No | Female | White | 67 | 6 - AREDS AMD Severity Scale Step 6 | 8 - AREDS AMD Severity Scale Step 8 |
AR2_0862 | ED148470 | General Research Use | No | Male | White | 71 | 6 - AREDS AMD Severity Scale Step 5 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0904 | ED148841 | General Research Use | No | Female | Black or African American | 67 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
AR2_0956 | ED149371 | General Research Use | No | Female | Black or African American | 57 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0969 | ED148812 | General Research Use | No | Female | Asian | 75 | 6 - AREDS AMD Severity Scale Step 6 | 6 - AREDS AMD Severity Scale Step 6 |
AR2_0974 | ED149965 | General Research Use | No | Male | White | 58 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
AR2_0978 | ED149823 | General Research Use | No | Female | White | 76 | 6 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
AR2_1056 | ED149583 | General Research Use | No | Male | Native Hawaiian or other Pacific | 79 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |